NACCME/Princeton CMENACCME/Princeton CME
First ReportManaged Care ConsultantCoalition of Rheumatology Educators (CORE)CME ForumCE ForumNP/PA ConsultantPrinceton Teleconference Series

Testing Center


CORE Programs
WorkShops
Symposiums
Teleconferences
Textbook
Video
Newsletters
Audio

Workshops

2008 CORE Regional Workshop Series

In 2008, the Coalition of Rheumatology Educators (CORE™) hosted 40 workshops nationwide, titled “Current Issues in Rheumatic Diseases.” The workshops were an overall success among participants, including rheumatologists and other healthcare professionals who manage rheumatoid arthritis (RA) and other rheumatic diseases. When asked to rate the educational activity on a scale of 1 to 5 (1 = poor; 5 = excellent), participants gave the workshops an overall score of 4.46.

During the workshops, experts in rheumatology presented current, evidence-based data through interactive, case-based presentations, which included an update with European League Against Rheumatism conference data. Engagement with the educational activity was evident, as participants gave the interactivity questions an overall score of 4.43.

A variety of relevant topics were discussed and debated at the workshops, including:

  • Early, aggressive therapy for RA to reach low disease activity or remission
  • Tight disease control through clinical measurement tools and imaging modalities
  • Safety issues of current therapy, including the risk of infection and malignancy in RA
  • Presence of related comorbidities, including the burden of cardiovascular disease

The cutting-edge CORE regional workshop series will return to a city near you in 2009.

Symposiums

2008 CORE Symposium

The 2008 Coalition of Rheumatology educators (CORE™) symposium, titled “Paving the Way for Best Practices in Managing Rheumatic Diseases,” was held at the annual American College of Rheumatology conference. The activity provided a fresh perspective on challenges surrounding rheumatoid arthritis (RA) and related rheumatic diseases, along with strategies to improve patient outcomes. Participants thought highly of the activity as the overall score, from a scale of 1 to 5 (1 = poor; 5 = excellent), was 4.46.

Rheumatology experts presented up-to-date information to a large audience of rheumatologists and other healthcare professionals who manage RA and spondyloarthropathies (SpA). The case-based, interactive session was well received, as participants gave the interactivity questions an overall score of 4.22.

Various topics were discussed at the symposium, including:

  • Diagnosis, treatment, and assessment strategies for RA and SpA
  • Safety issues surrounding RA and SpA management
  • The cardiovascular disease burden on patients with uncontrolled RA and SpA

Teleconferences

2008 CORE Teleconference Series

The 2008 Coalition of Rheumatology Educators (CORE™) live teleconference series offered rheumatologists and other healthcare professionals the opportunity to participate in interactive, educational activities on various dates during the year. The teleconferences included cutting-edge, evidence-based information on rheumatoid arthritis and spondyloarthropathies and a question and answer session with rheumatology experts.

Teleconferences engaged participants, as witnessed by overall ratings on a scale of 1 to 5 (1 = poor; 5 = excellent). The first teleconference series offered in 2008, titled “Optimizing Biologic Therapy and Clinical Assessment to Improve Outcomes in Rheumatoid Arthritis” received an overall score of 4.21. The second teleconference series in 2008, titled “Current Strategies for the Diagnosis, Management, and Assessment of the Spondyloarthropathies” received an overall score of 4.24.

Topics discussed during the teleconferences include:

  • Early, aggressive therapy with available DMARDs and targeted biologic agents
  • Tight disease control through clinical measurement tools and imaging modalities
  • Presence of related comorbidities, including the burden of cardiovascular disease

Audio recordings and slide presentations from the teleconferences are available on-demand for continuing education credit. To participate, please see the Home-Study Audio Webcasts section below.

Testimoials

The course was well prepared and presented information that was important for physicians. I was able to ask questions in a very relaxed atmosphere and receive answers that were practical and insightful. The opportunity to learn from experienced clinicians in a small group was wonderful.
—Robert Carpenter, MD, FACP, practicing rheumatologist, Chicago, IL

The American Academy of CME designates each chapter of this educational activity for a maximum of 1.25 (total maximum 13.75) AMA PRA Category 1 Credits™.

To view the CORE textbook online, click on the individual chapters.

Chapter

 

 

Introduction

1

Pathogenesis of Rheumatoid Arthritis and its Implications for Therapy—The Need for Early/Aggressive Therapy

2

Assessing Disease Status and Treatment Efficacy: Biomarkers and Clinical Measures of Rheumatoid Arthritis

3

Therapies and Management Strategies for Improved Outcomes in Rheumatoid Arthritis

4

Safety of Biologics in the Treatment of Rheumatoid Arthritis

5

Managing Comorbidities in Rheumatoid Arthritis

6

Juvenile Rheumatoid Arthritis—An Update in Management

7

Emerging Approaches: Review of Data on Newer Investigational Therapies for RA

8

Update on the Spondyloarthropathies and Advances in Treatment for Psoriatic Arthritis Reactive Arthritis, and Arthritis Associated with Inflammatory Bowel Disease

9

Advancing Effective Ankylosing Spondylitis Management

10

The Rationale for Biologic Therapy in Psoriasis: A New Therapeutic Option

11

Emerging Role of Biologic Therapy in Systemic Lupus Erythematosus

Video

4 Video Webcasts Totaling 2 CME Credits

Core Video Webcasts

Current Opportunities for Improving Patient Outcomes in Rheumatoid Arthritis

Participate in the interactive, educational Webcast “Current Opportunities for Improving Patient Outcomes in Rheumatoid Arthritis,” which discusses pertinent issues within rheumatoid arthritis, including the efficacy and safety of biologic therapies, the goal of reaching disease remission, and managing rheumatoid arthritis-related comorbidities.

View the Webcast

CORE

This newsletter, based on a roundtable discussion among rheumatology experts, focuses on safety and efficacy considerations surrounding the use of biologic therapy in the management of RA. In addition, the comorbid connection between uncontrolled RA and cardiovascular disease and the use of intensive clinical assessment through measurement tools and imaging modalities to maintain tight disease control are discussed in the newsletter.

The Evolution of Targeted Biologic Therapy and Aggressive Clinical Assessment in Rheumatoid Arthritis: Perspectives from a Roundtable of Rheumatology Experts

CORE

This newsletter focuses on the clinical presentation and measurements of disease activity of the spondyloarthropathies and on the available treatments. It is essential that clinicians stay abreast of the advances in these areas for optimal outcomes in the management of the spondyloarthropathies. Topics to be discussed include diagnostic criteria, assessment instruments, and current data on the efficacy of biologics in the treatment of psoriatic arthritis and ankylosing spondylitis.

Current Strategies for the Diagnosis and Management of Spondyloarthropathies


CORE


This is the second in a series of CORE newsletters titled “Managing Comorbidities in Rheumatoid Arthritis.” The newsletter discusses the connection between uncontrolled rheumatoid arthritis and the development of comorbid conditions and incorporates evidence-based approaches for the prevention and management of treatment adverse effects and rheumatoid arthritis-related comorbidities.

Managing Comorbidities in Rheumatoid Arthritis


CORE


This is the first in a series of CORE newsletters titled “Reaching the Goal of Remission in Rheumatoid Arthritis.” The newsletter discusses the concept of remission, whether patients with rheumatoid arthritis are reaching remission, and the various measurements and biomarkers currently used to assess remission status.

Reaching the Goal of Remission in Rheumatoid Arthritis

Optimizing Biologic Therapy and Clinical Assessment to Improve Outcomes in Rheumatoid Arthritis

On-demand Audio

Current Strategies for the Diagnosis, Management, and Assessment of the Spondyloarthropathies

On-demand Audio

Getting to Remission: Measurements vs Biomarkers vs Better Drugs

On-demand Audio

Managing Comorbidities in Rheumatoid Arthritis

On-demand Audio

Safety and Efficacy of Biologics in Rheumatoid Arthritis

On-demand Audio

Coalition of Rheumatology Educators (CORE)

The Coalition of Rheumatology Educators (CORE™) initiative is designed to enhance rheumatologists’ awareness of the need for early diagnosis and aggressive management of rheumatoid arthritis (RA) and the spondyloarthropathies and to better objectify assessment of disease activity, potentially leading to remission. Clinical experts in the field of rheumatology have developed educational content based on the latest published and presented data for live, print, and web-based CME programming in 2007 and will continue to work to develop content for live, print, and web-based CME programming in 2008, and to assess participant learning and ongoing educational needs.

CORE Faculty Members

Clifton O. Bingham III, MD
Assistant Professor of Medicine
Division of Rheumatology, Department of Medicine
Johns Hopkins University
Baltimore, Maryland

Leonard H. Calabrese, DO
Professor of Medicine, Cleveland Clinic Lerner
College of Medicine of Case Western Reserve University
RJ Fasenmyer Chair of Clinical Immunology
Theodore F Classen DO Chair of Osteopathic Research and Education
Vice Chairman, Department of Rheumatic and Immunologic Diseases
Cleveland, Ohio

John C. Davis, Jr., MD, MPH
Associate Professor of Medicine
University of California, San Francisco
San Francisco, California

Richard A. Furie, MD
Chief, Division of Rheumatology and Allergy-Immunology
North Shore-Long Island Jewish Health System
Lake Success, New York

Allan Gibofsky, MD*
Professor of Medicine and Public Health
Weill Medical College of Cornell University
New York, New York

Diana Goldenberg, MD, MPH
Hospital for Special Surgery
Weill Medical College of Cornell University
New York, New York

John A. Goldman, MD, FACR, FACP, CCD
Private Practice
Chief of Rheumatology
St. Joseph’s Hospital
President, Medical Quarters
Atlanta, Georgia

Kathryn F. Hobbs, MD
Associate Clinical Professor of Medicine
University of Colorado Denver
Director, Clinical Trials Unit
Denver Arthritis Clinic
Denver, Colorado

Arthur Kavanaugh, MD
Professor of Clinical Medicine
Director, Center for Innovative Therapy
Division of Rheumatology, Allergy, and Immunology
University of California San Diego School of Medicine
La Jolla, California

Jonathan Kay, MD
Director of Clinical Trials, Rheumatology Unit
Massachusetts General Hospital
Associate Clinical Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Edward Keystone, MD
Professor of Medicine, University of Toronto
Director, The Rebecca MacDonald Centre for Arthritis and Autoimmune Disease
Director, Division of Advanced Therapeutics in Arthritis
Mount Sinai Hospital
Toronto, Ontario, Canada

Muhammad A. Khan, MD, MACP, FRCP
Professor of Medicine
Case Western Reserve University
Cleveland, Ohio

Joel M. Kremer, MD
Pfaff Family Professor of Medicine
Albany Medical College
Director of Research
The Center for Rheumatology
Albany, New York

Carlos J. Lozada, MD
Associate Professor of Clinical Medicine
University of Miami Miller School of Medicine
Miami, Florida

Joseph A. Markenson, MD
Professor of Clinical Medicine
Weill Medical College of Cornell University
New York, New York

Philip J. Mease, MD*
Seattle Rheumatology Associates
Chief of Rheumatology Research
Swedish Medical Center
Clinical Professor of Medicine
University of Washington
Seattle, Washington

Eleanor Mody, MD
Director, Center for Skin and Related Musculoskeletal Conditions
Brigham and Women’s Hospital
Instructor of Medicine, Harvard Medical School
Boston, Massachusetts

Stephen A. Paget, MD
Professor of Medicine
Weill Medical College of Cornell University
New York, New York

Andreas Reiff, MD
Associate Professor of Pediatrics
Chief, Division of Pediatric Rheumatology and Rehabilitation
USC Keck School of Medicine
Childrens Hospital
Los Angeles, California

Christopher Ritchlin, MD
Professor of Medicine
Director, Clinical Immunology Research Center
Allergy, Immunology, and Rheumatology Division
University of Rochester Medical Center
Rochester, New York

Eric M. Ruderman, MD*
Associate Professor of Medicine
Division of Rheumatology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Sergio Schwartzman, MD
Associate Professor of Clinical Medicine
Weill Medical College of Cornell University
The Hospital for Special Surgery
New York Presbyterian Hospital
New York, New York

Vibeke Strand, MD, FACP
Adjunct Clinical Professor of Medicine
Division of Immunology & Rheumatology
Stanford University
Stanford, CA

Bruce E. Strober, MD, PhD
Assistant Professor
Associate Director of the Dermatology Clinical Trials Unit
NYU School of Medicine
Co-Director, Psoriasis and Psoriatic Arthritis Center
New York University Hospital
New York, New York

S. Bobo Tanner, MD
Assistant Professor of Medicine
Director, Osteoporosis Clinic
Divisions of Rheumatology, Allergy, & Immunology
Vanderbilt University Medical Center
Nashville, Tennessee

John R. P. Tesser, MD
Practicing Rheumatologist
Arizona Arthritis & Rheumatology Associates, P.C.
Clinical Lecturer
University of Arizona College of Medicine
Paradise Valley, Arizona

Arthur L. Weaver, MD
Clinical Professor Emeritus
Department of Medicine, Section of Rheumatology
University of Nebraska Medical Center
Omaha, Nebraska

Michael H. Weisman, MD
Director, Division of Rheumatology
Cedars-Sinai Medical Center
Professor of Medicine
UCLA School of Medicine

Alvin F. Wells, MD, PhD
Director, Rheumatology and Immunotherapy Center
Oak Creek, Wisconsin
Clinical Assistant Professor
Rosalind Franklin University of Medicine and Sciences
N. Chicago, Illinois
Adjunct Assistant Professor of Medicine
Duke University Medical Center
Durham, North Carolina

Yusuf Yazici, MD
Assistant Professor of Medicine
New York University School of Medicine
Director, Seligman Center for Advanced Therapeutics
NYU Hospital for Joint Diseases
New York, New York

2008 Chair, Advisory Board, CORE
Content Development

Marc D. Cohen, MD
Professor of Medicine
National Jewish Medical and Research Center
Denver, Colorado

* 2008 Advisory Board, CORE Content Development


Grant Support

CORE™ is supported by educational grants from Genentech, Inc and Biogen Idec Inc, Abbott Laboratories, Centocor, Inc, UCB, Inc, Bristol-Myers Squibb Company, and Amgen Inc and Wyeth Pharmaceuticals.


   

©Copyright 2003-2008 NACCME   Privacy Policy
Hardware/Software Requirements Disclosure Statement